Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2016 Apr 25;54(5):1404–1405. doi: 10.1128/JCM.00234-16

Clostridium difficile Ribotype 023 Lacks the Ability To Hydrolyze Esculin, Leading to False-Negative Results on Chromogenic Agar

Mairéad C Connor a, Derek J Fairley b, James P McKenna b, Nikki J Marks a, John W McGrath a,
Editor: A B Onderdonk
PMCID: PMC4844706  PMID: 26962090

LETTER

Clostridium difficile strains are toxigenic, spore forming, Gram-positive, anaerobic bacteria responsible for the majority of cases of colitis and antibiotic-associated diarrhea in the developed world (1). The use of chromogenic media for the rapid and specific detection of clinically important pathogens such as C. difficile has become widespread. Chromogenic agars rely on the ability of the microbe in question to break down or utilize a particular chromogenic substrate. For example, agar containing esculin, or one of its derivatives, such as 3,4-cyclohexenoesculetin-β-glucoside (CHE-β-glucoside), is used as a differential medium for C. difficile (2). The substrate is hydrolyzed to give glucose and esculetin, which reacts with ferric citrate, giving distinctive black colonies as a presumptive identification for C. difficile (Fig. 1) (36).

FIG 1.

FIG 1

C. difficile colonies on chromID C. difficile. (A) Standard black colonies produced by C. difficile on chromID. (B) Colorless colonies produced by C. difficile ribotype 023.

We have observed that some C. difficile strains fail to give a positive esculin hydrolysis test. Using a standard method (esculin broth with 0.07% [wt/vol] agar) (7), we tested representative strains from the five evolutionary clades of C. difficile (8) in triplicate: TL178 (clade 1, ribotype 002), R20291 (clade 2, ribotype 027), CD305 (clade 3, ribotype 023), CF5 (clade 4, ribotype 017), and M120 (clade 5, ribotype 078). Esculin hydrolysis was observed only in strains from clades 1, 2, 4, and 5: no esculin hydrolysis was detected in CD305, the clade 3 isolate.

The ability to hydrolyze esculin depends on possession of the appropriate β-glucosidase, esculinase (9). We hypothesize this may be nonfunctional or lacking in ribotype 023 strains from clade 3, and this may affect isolation and identification of these strains using chromogenic agar.

bioMérieux supplies a chromogenic agar, chromID C. difficile, for the specific detection of C. difficile within 24 h (10): C. difficile growth is characterized by the production of black colonies (Fig. 1) (11). We tested a further 35 clinical isolates of C. difficile ribotype 023. All isolates failed to produce black colonies on chromID C. difficile agar (Fig. 1), even after a 48-h incubation period. The C. difficile isolates included in the study were representative of ribotype 023 strains isolated over a period of 4 years from patients in Northern Ireland. Specimens originated from 8 different hospitals and from community patients throughout the region. One strain came from an unidentified hospital source in Scotland. Isolates were selected at random from these archived 023 strains.

The ribotype and toxigenicity of each isolate were confirmed using a previously published ribotyping method and toxin gene PCR (12). A total of 33 of the 35 isolates were also analyzed using multilocus variable-number tandem-repeat analysis (MLVA) (13). Thirty different MLVA profiles were detected and could be grouped into at least 15 distinct genotypes defined by a summed tandem-repeat difference of 3 or more (14), confirming the strains tested were genetically diverse. All of the isolates in this collection of 023 strains failed to produce black colonies on chromID C. difficile chromogenic agar. In addition, one (non-023) nongroupable isolate from our collection also gave colorless colonies, indicating this phenotype may be seen in other strains.

Ribotype 023 is consistently in the top 10 most common ribotypes found to be causing infection (15), so it is important that diagnostic laboratories using chromID C. difficile medium, or any esculin-based assay, are aware of this and that further confirmatory tests may be required. Ribotype 023 strains do indeed give the typical irregular colony morphology associated with C. difficile on chromID C. difficile agar, but the white/colorless colonies could be overlooked during routine testing. We wish to highlight this trait, as it may affect isolation and identification of this clinically significant ribotype when using chromID C. difficile agar or similar esculin-based products.

REFERENCES

  • 1.Bartlett JG. 2006. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145:758–764. doi: 10.7326/0003-4819-145-10-200611210-00008. [DOI] [PubMed] [Google Scholar]
  • 2.James AL, Perry JD, Ford M, Armstrong L, Gould FK. 1997. Cyclohexenoesculetin-beta-d-glucoside: a new substrate for the detection of bacterial beta-d-glucosidase. J Appl Microbiol 82:532–536. doi: 10.1046/j.1365-2672.1997.00370.x. [DOI] [PubMed] [Google Scholar]
  • 3.MacFaddin JF. 1981. Biochemical tests for identification of medical bacteria, 2nd ed Williams & Wilkins, Philadelphia, PA. [Google Scholar]
  • 4.Lozniewski A, Rabaud C, Dotto E, Weber M, Mory F. 2001. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of premier cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 39:1996–1998. doi: 10.1128/JCM.39.5.1996-1998.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Qadri SM, Johnson S, Smith JC, Zubairi S, Gillum RL. 1981. Comparison of spot esculin hydrolysis with the PathoTec strip test for rapid differentiation of anaerobic bacteria. J Clin Microbiol 13:459–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sultana Q, Chaudhry NA, Munir M, Anwar MS, Tayyab M. 2000. Diagnosis of Clostridium difficile antibiotic associated diarrhoea culture versus toxin assay. J Pak Med Assoc 50:246–249. [PubMed] [Google Scholar]
  • 7.Verlasovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed). 2011. Manual of clinical microbiology, 10th ed American Society for Microbiology Press, Washington, DC. [Google Scholar]
  • 8.Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M, Stoesser N, Jolley KA, Golubchik T, Harding RM, Peto TE, Fawley W, Walker AS, Wilcox M, Crook DW. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993. doi: 10.1371/journal.pone.0019993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Edberg SC, Bell SR. 1985. Lack of constitutive beta-glucosidase (esculinase) in the genus Fusobacterium. J Clin Microbiol 22:435–437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Eckert C, Burghoffer B, Lalande V, Barbut F. 2013. Evaluation of the chromogenic agar chromID C. difficile. J Clin Microbiol 51:1002–1004. doi: 10.1128/JCM.02601-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cellier M, Halimi D, Orenga S. May 2013. Use of a beta-glucosidase activator for the detection and/or identification of C. difficile. US patent 20130137126 A1.
  • 12.Fairley DJ, McKenna JP, Stevenson M, Weaver J, Gilliland C, Watt A, Coyle PV. 2015. Association of Clostridium difficile ribotype 078 with detectable toxin in human stool specimens. J Med Microbiol 64:1341–1345. doi: 10.1099/jmm.0.000165. [DOI] [PubMed] [Google Scholar]
  • 13.van den Berg RJ, Schaap I, Templeton KE, Klaassen CHW, Kuijper EJ. 2007. Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol 45:1024–1028. doi: 10.1128/JCM.02023-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. 2013. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57:1094–1102. doi: 10.1093/cid/cit475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MWD. 2012. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55:1056–1063. doi: 10.1093/cid/cis614. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES